The FDA said it was aware of increased use of the medicines hydroxychloroquine and chloroquine through outpatient prescriptions.
April 24 - The U.S. Food and Drug Administration on Friday cautioned against the use of malaria drugs, hydroxychloroquine and chloroquine, in COVID-19 patients outside of hospitals and clinical trials, citing risks of serious heart rhythm problems.
The agency’s announcement comes a day after the European Union’s drug regulator warned of the drugs’ side effects and urged medical professionals to closely monitor patients on the medicines.said it was aware of increased use of these medicines through outpatient prescriptions and the drugs could causeDecades-old hydroxychloroquine has been touted by U.S.
However, the drug provided no benefit and potentially higher risk of death for patients at U.S. veterans hospitals, according to an analysis that was submitted for expert review earlier this week.has allowed healthcare providers to use the drug for COVID-19 through its emergency use authorization, but the drug is not approved to treat the disease.
The heart rhythm risks may increase when the medicines are combined with other drugs, such as antibiotic azithromycin, as well as in patients with existing heart and kidney disease, the
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA warns against malaria drug's COVID-19 use outside hospitalsThe U.S. Food and Drug Administration on Friday cautioned against the use of malaria drug hydroxychloroquine, touted by President Donald Trump, in COVID-19 patients outside of hospitals and clinical trials, citing risks of serious heart rhythm problems.
Read more »
U.S. FDA warns against malaria drugs Trump championed for COVID-19The U.S. Food and Drug Administration on Friday cautioned against the use of malaria drug hydroxychloroquine in COVID-19 patients even as President Donald Trump, who has touted it as a 'game changer,' advocated for an additional review.
Read more »
FDA Warns Against Malaria Drugs to Treat COVID-19Malaria drugs touted by President Donald Trump as potential 'game changers' against COVID-19 are actually too dangerous for general use, the FDA has warned.
Read more »
FDA Warns Against Wide Use Of The Drugs Trump Hailed As 'Game Changers'The agency said Friday that using hydroxychloroquine and a related compound, chloroquine, for COVID-19 may cause life-threatening side effects. That warning contradicts the president's own enthusiasm.
Read more »
FDA Warns Against Using Drugs Promoted By Trump After Reports Of ‘Poisoning And Death’The antimalarial drugs should only be used to treat coronavirus patients in a supervised healthcare setting, the agency urged.
Read more »